46 results about "Human specific" patented technology

Collecting images of a patron in an entertainment venue is performed by facial recognition of the patron's face within the images, simplifying the storage and distribution of the images for a patron. In order to enhance the reliability of the facial recognition system, information about the patron that is not directly related to most facial recognition systems, including clothes, height, other associated people, use of glasses and jewelry, disposition of facial hair, and more, can be used. Some of the characteristics used can be specific to a particular date or event, and which will not be more generally characteristic of the patron. The facial recognition system can also be used to identify the patron requesting images to be collected. The present invention also relates to the use of facial recognition in sorting and collecting images from an electronically-stored image collection, enabling the easy retrieval of images that are related to a particular person or set of people.

Systems and methods are provided for validating the authenticity of a signature on a document by providing a document from an account, the document including an actual signature and a machine-readable identifier, wherein the machine-readable identifier contains a string of data representing the integral characteristics of all valid account signatures and a person-specific confidence threshold. When the document is presented at a point of presentment, the document is scanned into a document-processing machine and the actual signature is compared against all valid account signatures.

Systems and methods are provided for validating the authenticity of a signature on a document by providing a document from an account, the document including an actual signature and a machine-readable identifier, wherein the machine-readable identifier contains a string of data representing the integral characteristics of all valid account signatures and a person-specific confidence threshold. When the document is presented at a point of presentment, the document is scanned into a document-processing machine and the actual signature is compared against all valid account signatures.

Systems and methods are provided for validating the authenticity of a signature on a document by providing a document from an account, the document including an actual signature and a machine-readable identifier, wherein the machine-readable identifier contains a string of data representing the integral characteristics of all valid account signatures and a person-specific confidence threshold. When the document is presented at a point of presentment, the document is scanned into a document-processing machine and the actual signature is compared against all valid account signatures.

A method and apparatus for video retrieval and cueing that automatically detects human faces in the video and identifies face-specific video frames so as to allow retrieval and viewing of person-specific video segments. In one embodiment, the method locates human faces in the video, stores the time stamps associated with each face, displays a single image associated with each face, matches each face against a database, computes face locations with respect to a common 3D coordinate system, and provides a means of displaying: 1) information retrieved from the database associated with a selected person or people, 2) path of travel associated with a selected person or people 3) interaction graph of people in video, 4) video segments associated with each person and / or face. The method may also provide the ability to input and store text annotations associated with each person, face, and video segment, and the ability to enroll and remove people from database. The videos of non-human objects may be processed in a similar manner. Because of the rules governing abstracts, this abstract should not be used to construe the claims.

Systems and methods are provided for validating the authenticity of a signature on a document by providing a document from an account, the document including an actual signature and a machine-readable identifier, wherein the machine-readable identifier contains a string of data representing the integral characteristics of all valid account signatures and a person-specific confidence threshold. When the document is presented at a point of presentment, the document is scanned into a document-processing machine and the actual signature is compared against all valid account signatures.

The invention relates to a PDL1 monoclonal antibody and application thereof and belongs to the technical field of immunology. A separated human specific binding molecule provided by the invention comprises a) and b), wherein a) three light-chain CDRs comprise a light-chain CDR1, a light-chain CDR2 and a light-chain CDR3; b) three heavy-chain CDRs comprise a heavy-chain CDR1, a heavy-chain CDR2 anda heavy-chain CDR3; the separated human PDL1 specific binding molecule is a separated antibody or antigen binding fragment. The PDL1 monoclonal antibody provided by the invention can be used for effectively inhibiting partial tumor growth; a PD1 / PDL1 signal is blocked so that the proliferation of tumor antigen specific T cells can be accelerated and the effect of killing tumor cells is realized;a related PDL1 signal on the tumor cells is blocked so that the secretion of an infiltrated CD8<+>T cell IFN-gamma can be up-regulated.

The invention discloses a distributed DTW (Dynamic Time Warping) human behaviour intention identification method based on human behaviour characteristics. The distributed DTW human behaviour intention identification method based on the human behaviour characteristics comprises the following steps of: obtaining human behaviour characteristics in a current frame, and adding the human behaviour characteristics in the current frame into a human behaviour characteristic time sequence; matching a currently observed human behaviour characteristic sequence with a learned specific behaviour sequence in a database template by utilizing a DTW algorithm, and calculating the best matching similarity of the two based on a chi-square distance; reversing the similarity, and performing normalization to obtain a matching probability; and, taking an action mode probability value of each sensor as consistency information amount, performing data exchange with an adjacent sensor again, and performing consistency iterative operation, so that identification results of adjacent sensor nodes are same finally. By means of the distributed DTW human behaviour intention identification method based on the human behaviour characteristics disclosed by the invention, precise human specific behaviour identification can be realized.

Disclosed is a method for managing diabetes by reducing the post-prandial blood glucose spike, or the glucose shock. The blood glucose spike, or the glucose shock is reduced by generating a person-specific glucose profile for at least one significant meal to tune or train a blood glucose model (kinetic, artificial intelligence or hybrid), and then using the tuned or the trained model embedded in a computation-capable electronic device to compute and recommend a person-specific meal plan and an exercise plan, including semi-continuous meal ingestion and post-meal exercise while sitting at home or office. Advantages over prior art are that the method uses less strenuous exercise with no or less medicine, is person-specific, quantitative and more suitable for use by an individual, a dietician, or a health care practitioner.

The invention relates to a method to select the cross reacting antigen by the computer auxiliary. It sets the protein data bank of the pathogeny microorganism and the human specific histiocyte, then to get the preset length of the similar subsequence by the local sequence comparing arithmetic; it sets the data bank of the linear epitope and the nonlinear epitope of the B cells to support the training of the SVM which predicts the probability of the linear epitope of the B cells. It selects the big probability of the similar subsequence according to the probability of the linear epitope of the B cells. The invention has decreased the experiment workload for the immunologist.

The present invention includes a plurality of layered materials used to facilitate the removal of sweat and toxins which a person may experience during a physical workout. It is useful for sanitarily wicking away sweat and various other functions which may be specific to a person's needs such as carrying important items.

The invention relates to a healthcare garment capable of treating cold-coagulation and blood-stasis type dysmenorrhea. The healthcare garment comprises a garment body, a heating device and medicine bags, the heating device comprises a carbon fiber heating wire and heating units, the garment body comprises outer-layer cloth and inner-layer cloth, and positions, corresponding to specific meridians and collaterals of a human body, of the carbon fiber heating wire are arranged between the outer-layer cloth and the inner-layer cloth and connected with the heating unit. The specific meridians and collaterals include foot-yangming stomach meridian, foot-taiyin spleen meridian, foot-taiyang bladder meridian, foot-shaoyin kidney meridian, Ren channel, Du channel and Dai channel; the medicine bags and the heating units are arranged positions, corresponding to human specific acupoints, of the garment body in a one-to-one pairwise manner, and the specific acupoints include Shanzhong, Guanyuan, Ganyu, Guilai, Zhongji, Zusanli, Diji, Sanyinjiao, Ciliao, Taichong and Yongquan acupoints. Corresponding meridians and collaterals and acupoints are heated for the cold-coagulation and blood-stasis typedysmenorrhea, so that pertinence is high. The acupoints and the medicine bags are selected reasonably, and repeated verification shows that the healthcare garment has remarkable treatment effect on the cold-coagulation and blood-stasis type dysmenorrheal.

The purpose of the present invention is to provide a transgenic non-human animal with which it is possible to appropriately evaluate characteristics, pharmacological effects, and safety of molecularlytargeted substances or drugs with respect to human-specific molecules, and to provide a manufacturing method therefor. The transgenic non-human animal is subjected to transgenesis by using genes coding for human-specific molecules and genes coding for the human Fc gamma receptor family, thus expressing the genes coding for the human-specific molecules and the genes coding for the human Fc gamma receptor family.

The invention provides a method for measuring distribution of a human cell drug in an animal body, comprising the following steps of: (1) selecting a PCR(polymerase chain reaction) amplification region according to a human specific gene and designing a PCR amplification primer; (2) extracting human genome DNA(deoxyribonucleic acid), carrying out PCR amplification on a target gene fragment; (3) connecting the amplified fragment with a T vector to construct a standard plasmid; (4) establishing a standard curve by using the standard plasmid; (5) after the human cell drug is applied to an animal, collecting tissues, extracting a total DNA sample to carry out quantitative PCR reaction; and (6) calculating the contents of human genome DNA in the total DNA sample of each tissue by the standard curve, thereby calculating the contents of the human cell drug in the tissues. The measuring method provided by the invention has simple experimental processes and accurate and reliable experimental results.

The invention provides a kit for detection BCR diversity. The kit comprises a set of multiple PCR primers. The multiple PCR primer contains upstream primers and downstream primers. The upstream primers are composed of a group of sequences which have a one-to-one correspondence with nucleotide sequences as shown in SEQ ID NO:1- SEQ ID NO: 13. Sequences in the upstream primer have 0-3 more or less nucleotides than the corresponding sequences in the SEQ ID NO:1- SEQ ID NO:13. The downstream primers are composed of a group of sequences which have a one-to-one correspondence with nucleotide sequences as shown in SEQ ID NO:14- SEQ ID NO:17. Sequences in the downstream primer have 0-3 more or less nucleotides than the corresponding sequences in the SEQ ID NO:14- SEQ ID NO:17. By the use of the kit, BCR sequences of human can be efficiently obtained, human specific BCR CDR3 sequences are obtained, and detection rate of low-copy-number B cell clones can be raised.

A method for isolating human neuroepithelial precursor cells from human fetal tissue by culturing the human fetal cells in fibroblast growth factor and chick embryo extract and immunodepleting from the cultured human fetal cells any cells expressing A2B5, NG2 and eNCAM is provided. In addition, methods for transplanting these cells into an animal are provided. Animals models transplanted with these human neuroepithelial precursor cells and methods for monitoring survival, proliferation, differentiation and migration of the cells in the animal model via detection of human specific markers are also provided.

A system and method for non-invasive reconstruction of an entire object-specific or person-specific teeth row from just a set of photographs of the mouth region of an object (e.g., an animal) or a person (e.g., an actor or a patient) are provided. A teeth statistic model defining individual teeth in a teeth row can be developed. The teeth statistical model can jointly describe shape and pose variations per tooth, and as well as placement of the individual teeth in the teeth row. In some embodiments, the teeth statistic model can be trained using teeth information from 3D scan data of different sample subjects. The 3D scan data can be used to establish a database of teeth of various shapes and poses. Geometry information regarding the individual teeth can be extracted from the 3D scan data. The teeth statistic model can be trained using the geometry information regarding the individual teeth.

The invention relates to a method to select the cross reacting antigen by the computer auxiliary. It sets the protein data bank of the pathogeny microorganism and the human specific histiocyte, then to get the preset length of the similar subsequence by the local sequence comparing arithmetic; it sets the data bank of the linear epitope and the nonlinear epitope of the B cells to support the training of the SVM which predicts the probability of the linear epitope of the B cells. It selects the big probability of the similar subsequence according to the probability of the linear epitope of the B cells. The invention has decreased the experiment workload for the immunologist.